HIGHLIGHTS
- who: Schu00f6ttker et_al BMC Cancer and collaborators from the (UNIVERSITY) have published the research work: STUDY PROTOCOL, in the Journal: (JOURNAL)
- what: The aim of the randomized controlled Optimization of Polypharmacy in Geriatric Oncology (OPTIMAL) trial is to test whether an advisory letter with the results of a comprehensive medication review conducted with the Fit fOR In the oncology departments of approximately 10 German rehabilitation clinics the authors aim to recruit 514 patients (22 common cancers; diagnosis or recurrence requiring treatment in the last 5 years; all stages) who are u2265 65 years old regularly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.